shall be deemed the acquisition of assets of the company pursuant to the Notification of the Capital Market Supervisory Board No. Tor Chor. 20/2551, Re: Rules on Entering into Material Transaction deemed
subsidiary shall be deemed the acquisition of assets of the company pursuant to the Notification of the Capital Market Supervisory Board No. Tor Chor. 20/2551, Re: Rules on Entering into Material Transaction
- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager
Companies against the Incorrect Selling Price or Redemption Price of Investment Units of Open-End Funds, dated 2 May 2000, shall be repealed. Clause 2 . In this Notification: “Management company” means a
against the Incorrect Selling Price or Redemption Price of Investment Units of Open-End Funds, dated 2 May 2000, shall be repealed. Clause 2. In this Notification: “Management company” means a securities
Incorrect Selling Price or Redemption Price of Investment Units of Open-End Funds, dated 2 May 2000, shall be repealed. Clause 2. In this Notification: “Management company” means a securities company licensed
-Translation- NO. ED-MD2020-0009 March 12th, 2020 Subject: Notification of Acquisition Assets To: Director and General Manager The Stock Exchange of Thailand Enclosed Report Eureka Design Public
the Company’s shareholding in CCPT-KY therefore shall be considered as a disposition of assets of a listed company according to the Notification of Capital Market Supervisory Board No. TorChor. 20/2551
Concerning the Acquisition and Disposition of Assets, 2004 (including additional amendments) (the “Notification on Acquisition and Disposition”). However, the Company discloses information memorandum relating